Prevalence of Self-Reported Hypertension 30 Percent in 2017 to 2021
By Elana Gotkine HealthDay Reporter
MONDAY, March 11, 2024 -- The overall age-standardized prevalence of hypertension was about 30 percent in 2017 to 2021, according to research published in the March 7 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Ahlia Sekkarie, Ph.D., from the CDC in Atlanta, and colleagues analyzed data from the Behavioral Risk Factor Surveillance System for 2017 to 2021 to examine the prevalence of diagnosed hypertension and antihypertensive medication use.
The researchers found that age-standardized, self-reported diagnosed hypertension was about 30 percent during 2017 to 2021, with persistent differences observed by age, sex, race and ethnicity, education level, and state of residence. Among persons with hypertension, the age-standardized prevalence of antihypertensive medication use increased from 59.8 to 62.9 percent during this period. Most sociodemographic groups and many states had increases in antihypertensive medication use.
"Knowledge of trends in diagnosed hypertension and treatment is an essential tool for guiding state-level, individual, clinical, and public health policies and interventions, such as those promoted by the Million Hearts national initiative, to prevent cardiovascular disease," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Novel Genetic Loci ID'd for Hypertension in European Ancestry
TUESDAY, May 7, 2024 -- A total of 113 novel genetic loci have been identified in the largest single-stage common variant genome-wide association study of blood pressure (BP)...
Long-Term Risk for MACE Increased for Children With Hypertension
TUESDAY, May 7, 2024 -- The long-term risk for major adverse cardiac events (MACE) is increased for children diagnosed with hypertension, according to a study published online May...
Intensive HTN Treatment Cuts Early T2D Diagnosis-Linked CVD Event Risk
MONDAY, April 29, 2024 -- More intensive hypertensive therapy significantly reduces the excess risk for cardiovascular disease (CVD) events associated with earlier hypertension...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.